arrow
N

Noriyoshi Iriyama

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
H指数:21
被引数:1,501

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents

评估英国骨髓瘤研究联盟风险特征在移植不适用的新型药物治疗的复发性骨髓瘤患者中的应用

2026-09-060
PRE
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs

CML接受第二代TKI治疗后达到MR4.5及TKI停药资格的早期预测因子

2026-08-251
PRE
Treatment-free remission and immune profiling after frontline second-generation TKI therapy in CML

无治疗缓解及免疫图谱分析:慢性粒细胞白血病一线二代TKI治疗后的结果

2026-06-220
OA
Geriatric assessment-based therapy for older patients with diffuse large B-cell lymphoma: results of a two-decade clinical experience

基于老年评估的治疗方案在弥漫性大B细胞淋巴瘤老年患者中的应用:二十年临床经验的结果

2026-04-250
OAAI
Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in Japan

J-SKI五年中期分析:日本慢性粒细胞白血病患者酪氨酸激酶抑制剂停药情况的观察性研究

2026-03-012
PRE
Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia

基于血液检测的治疗反应预测评分工具的开发,用于慢性髓性白血病

2025-12-010
PRE
Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group

达拉妥单抗联合疗法在具有不成熟表型的多发性骨髓瘤患者中的良好疗效:J-CHARGE研究组的报告

2025-11-010
PRE
Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM database

新诊断多发性骨髓瘤患者早期死亡的研究:来自使用J-CHAEGE-MM数据库的真实世界队列的见解

2025-10-010
PRE
Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers' polycythemia and polycythemia vera

引入加热不燃烧烟草可改善吸烟者红细胞增多症和红细胞增多症患者的红细胞压积及与吸烟相关的症状。

2025-05-280
OA
Nilotinib vs dasatinib in achieving MR 4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study
2024-10-090
OAAI
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)

日本多发性骨髓瘤患者每周一次卡非佐米的观察性研究 (每周CAR研究)

2024-02-290
OAAI
Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study
2022-07-080
PRE
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11
2020-01-0372
OAAI
Potential role for second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis
2019-09-271
OA
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database
2018-06-2622
PREAI